Preferred Label : HLA-A*2402-Restricted Multipeptide Vaccine S-488410;
NCIt definition : A cancer vaccine composed of HLA-*2402-restricted epitopic peptides derived from three
cancer/testis (CT) antigens, with potential antineoplastic activity. Upon subcutaneous
administration, HLA-A*2402-restricted multipeptide vaccine S-488410 may elicit a cytotoxic
T-lymphocyte (CTL) response against tumor cells expressing these CT antigens. CT antigens,
normally expressed only in germ cells of the testis, are overexpressed in a wide variety
of human cancers.;
Molecule name : S-488410;
NCI Metathesaurus CUI : CL436276;
Origin ID : C101893;
UMLS CUI : C3640297;
Semantic type(s)
- chemical_or_drug_has_mechanism_of_action
- concept_is_in_subset
